139 related articles for article (PubMed ID: 17637748)
1. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
2. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Am J Pathol; 1999 Feb; 154(2):543-51. PubMed ID: 10027412
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.
Nakashiro K; Hara S; Shinohara Y; Oyasu M; Kawamata H; Shintani S; Hamakawa H; Oyasu R
Am J Pathol; 2004 Aug; 165(2):533-40. PubMed ID: 15277227
[TBL] [Abstract][Full Text] [Related]
5. Stromal anti-apoptotic androgen receptor target gene c-FLIP in prostate cancer.
Ye H; Li Y; Melamed J; Pearce P; Wei J; Chiriboga L; Wang Z; Osman I; Lee P
J Urol; 2009 Feb; 181(2):872-7. PubMed ID: 19095249
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin has a cytoprotective role against endoplasmic reticulum stress for pancreatic β-cells in autocrine and paracrine manners.
Suetomi R; Ohta Y; Akiyama M; Matsumura T; Taguchi A; Yamamoto K; Kamatani T; Tanizawa Y
J Diabetes Investig; 2020 Jul; 11(4):823-833. PubMed ID: 31989791
[TBL] [Abstract][Full Text] [Related]
7. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.
Azur RAG; Olarte KCV; Ybañez WS; Ocampo AMM; Bagamasbad PD
PLoS One; 2024; 19(5):e0300413. PubMed ID: 38739593
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.
Holzbeierlein J; Lal P; LaTulippe E; Smith A; Satagopan J; Zhang L; Ryan C; Smith S; Scher H; Scardino P; Reuter V; Gerald WL
Am J Pathol; 2004 Jan; 164(1):217-27. PubMed ID: 14695335
[TBL] [Abstract][Full Text] [Related]
9. TCTP is an androgen-regulated gene implicated in prostate cancer.
Kaarbø M; Storm ML; Qu S; Wæhre H; Risberg B; Danielsen HE; Saatcioglu F
PLoS One; 2013; 8(7):e69398. PubMed ID: 23894469
[TBL] [Abstract][Full Text] [Related]
10. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.
True LD; Buhler K; Quinn J; Williams E; Nelson PS; Clegg N; Macoska JA; Norwood T; Liu A; Ellis W; Lange P; Vessella R
Am J Pathol; 2002 Aug; 161(2):705-15. PubMed ID: 12163395
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor signaling regulates T-type Ca
Hall M; Todd B; Allen ED; Nguyen N; Kwon YJ; Nguyen V; Hearne JL; Martin-Caraballo M
Am J Cancer Res; 2018; 8(4):732-747. PubMed ID: 29736318
[TBL] [Abstract][Full Text] [Related]
12. Serotonin Pathway in Cancer.
Balakrishna P; George S; Hatoum H; Mukherjee S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525332
[TBL] [Abstract][Full Text] [Related]
13. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.
Sánchez ML; Rodríguez FD; Coveñas R
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980580
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis.
Benyahia Z; Gaudy-Marqueste C; Berenguer-Daizé C; Chabane N; Dussault N; Cayol M; Vellutini C; Djemli A; Nanni I; Beaufils N; Mabrouk K; Grob JJ; Ouafik L
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497391
[TBL] [Abstract][Full Text] [Related]
15. Endocrine and paracrine characteristics of neuroendocrine prostate cancer.
Arman T; Nelson PS
Front Endocrinol (Lausanne); 2022; 13():1012005. PubMed ID: 36440195
[TBL] [Abstract][Full Text] [Related]
16. Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation.
Merkens L; Sailer V; Lessel D; Janzen E; Greimeier S; Kirfel J; Perner S; Pantel K; Werner S; von Amsberg G
J Exp Clin Cancer Res; 2022 Feb; 41(1):46. PubMed ID: 35109899
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.
Slabáková E; Kahounová Z; Procházková J; Souček K
Noncoding RNA; 2021 Dec; 7(4):. PubMed ID: 34940756
[TBL] [Abstract][Full Text] [Related]
18. Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
Vázquez R; Riveiro ME; Berenguer-Daizé C; O'Kane A; Gormley J; Touzelet O; Rezai K; Bekradda M; Ouafik L
Front Oncol; 2020; 10():589218. PubMed ID: 33489885
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells.
Samiea A; Yoon JSJ; Ong CJ; Zoubeidi A; Chamberlain TC; Mui AL
Prostate Cancer; 2020; 2020():5305306. PubMed ID: 32802517
[TBL] [Abstract][Full Text] [Related]
20. EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.
Soundararajan R; Paranjape AN; Maity S; Aparicio A; Mani SA
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):229-238. PubMed ID: 29981816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
